Motor Parameters in Patients With Limb Girdle Muscular Dystrophy

NCT ID: NCT04772027

Last Updated: 2023-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-01

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the study is to perform 2-year follow up with motor parameters evolution using instrumental assessments in patients with limb girdle muscular dystrophie, and to identify which motor parameters are sensitive to change.

The secondary objectives of the study are:

* to describe the changes of the parameters obtained from instrumental evaluations in comparison with the changes obtained from clinical assessments.
* to characterize the muscular impairments, the biomechanical gait disorders, the standing postural control disorders, the biomechanical upper limb disorders in spatial exploration, the limitation of upper limb capacities, the fatigue, the endurance, the patients' participation to their activities and their quality of life, in comparison with a healthy paired population.
* to highlight the relationships between muscular assessment parameters, biomechanical gait parameters, standing posture control and upper limb spatial exploration.
* to highlight the relationships between data from instrumental assessments and data from clinical assessments.
* to highlight the relationships between instrumental assessments data and clinical assessments data on one side, and features of patients (age, sex, duration since diagnosis, type of LGMD, rehabilitation in follow-up, sportive practices...) on the other side.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a monocentric study in which 2 sub-groups of people will be enrolled: LGMD patients and healthy volunteers. Each enrolled LGMD patient will have 5 visits during 2 years, one baseline visit and four half-yearly visits. Each enrolled healthy volunteer will have one planned visit only. The duration of enrollments will last 20 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Limb Girdle Muscular Dystrophies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Muscular dystrophies group

40 patients with limb girdle muscular dystrophie

No interventions assigned to this group

Comparator group

40 healthy volunteers without neuromuscular or squeletic disorder

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For limb girdle muscular dystrophie group:

* Patients diagnosed limb girdle muscular dystrophie;
* Aged between 18 and 70 years;
* Covered by the French social security scheme;
* Patient able to maintain upright position alone;
* Able to walk at least 10 meters and 6 minutes consecutively without help.
* For Volunteer group:

* Adult (18 to 70 years) without neuromuscular or squeletic disorder.

Exclusion Criteria

§ For all:

* Without associated neuromuscular disorders such as respiratory or muscular-squeletic diseases, apart from the consequences of dystrophy;
* Contraindication to the tests;
* Noncontrol cardiac rhythm disorders;
* Lying down position intolerance due to severe respiratory troubles;
* Pregnant or breastfeeding woman.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Céline BONNYAUD, PhD

Role: PRINCIPAL_INVESTIGATOR

Laboratoire d'analyse du mouvement, Service d'explorations fonctionnelles, Hôpital Raymond Poincaré, APHP

Samuel POUPLIN

Role: STUDY_DIRECTOR

Plateforme Nouvelles Technologies, Hôpital Raymond Poincaré, APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratoire d'analyse du mouvement, Service d'exploration fonctionnelles, Hôpital Raymond Poincaré, APHP

Garche, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Céline BONNYAUD, PhD

Role: CONTACT

+33 (0)1 71 14 49 21

Samuel POUPLIN

Role: CONTACT

+33 (0)1 47 10 70 61

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02090-39

Identifier Type: REGISTRY

Identifier Source: secondary_id

APHP200141

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Imaging and Gait Analysis in FSHD Patients
NCT07164937 ENROLLING_BY_INVITATION